These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Guidelines on the clinical use of leucocyte-depleted blood components. British Committee for Standards in Haematology, Blood Transfusion Task Force. Transfus Med; 1998 Mar; 8(1):59-71. PubMed ID: 9569462 [No Abstract] [Full Text] [Related]
6. Leukocyte reduction of cellular blood components. Effectiveness, benefits, quality control, and costs. Lane TA Arch Pathol Lab Med; 1994 Apr; 118(4):392-404. PubMed ID: 8166589 [TBL] [Abstract][Full Text] [Related]
7. Leukocyte reduction in blood component therapy. Lane TA; Anderson KC; Goodnough LT; Kurtz S; Moroff G; Pisciotto PT; Sayers M; Silberstein LE Ann Intern Med; 1992 Jul; 117(2):151-62. PubMed ID: 1605430 [TBL] [Abstract][Full Text] [Related]
8. New technologies for the inactivation of infectious pathogens in cellular blood components and the development of platelet substitutes. Corash L Baillieres Best Pract Res Clin Haematol; 2000 Dec; 13(4):549-63. PubMed ID: 11102276 [TBL] [Abstract][Full Text] [Related]
10. Dual reduction in the immunologic and infectious complications of transfusion by filtration/removal of leukocytes from donor blood soon after collection. Rawal BD; Davis RE; Busch MP; Vyas GN Transfus Med Rev; 1990 Oct; 4(4 Suppl 1):36-41. PubMed ID: 2134639 [No Abstract] [Full Text] [Related]
14. Immunosuppressive effects of allogeneic blood transfusions: implications for the patient with a malignancy. Bordin JO; Blajchman MA Hematol Oncol Clin North Am; 1995 Feb; 9(1):205-18. PubMed ID: 7737942 [TBL] [Abstract][Full Text] [Related]
15. Transfusion strategies in patients undergoing stem-cell transplantation. Radia R; Pamphilon D Expert Rev Hematol; 2011 Apr; 4(2):213-20. PubMed ID: 21495930 [TBL] [Abstract][Full Text] [Related]
16. [Risk of immunization to blood cells and diagnostic and therapeutic implications]. Kiefel V Beitr Infusionsther; 1993; 31():44-51. PubMed ID: 7693263 [TBL] [Abstract][Full Text] [Related]
17. From leukocyte reduction to leukocyte transfusion: the immunological effects of transfused leukocytes. Lee JH; Klein HG Baillieres Best Pract Res Clin Haematol; 2000 Dec; 13(4):585-600. PubMed ID: 11102278 [TBL] [Abstract][Full Text] [Related]
18. From whole blood to component therapy: the economic, supply/demand need for implementation of component therapy in sub-Saharan Africa. Erhabor O; Adias TC Transfus Clin Biol; 2011 Dec; 18(5-6):516-26. PubMed ID: 22037104 [TBL] [Abstract][Full Text] [Related]